Clinical library

Every tool, one focused workspace.

1,329 calculators and references across 60 specialties, with formula confidence shown up front.

Interactive worksheet

LECOM (Lead Extraction COMplexity) Score Calculator

LECOM (Lead Extraction COMplexity) Score: Explanation and Clinical Context The LECOM score is a predictive tool developed to assess the complexity of transvenous lead extraction (TLE) procedures. It incorporates clinical and procedural factors to estimate the likelihood of a difficult extraction. The score is calculated based on the following parameters: - Age at First CIED Implantation: Patients implanted before 51

Interactive worksheet

LV End-Systolic Volume Reduction Index (LVESVRI) Calculator

LV End-Systolic Volume Reduction Index (LVESVRI): Explanation and Clinical Context LVESVRI is a measure of left ventricular reverse remodeling, calculated as the percentage reduction in LV end-systolic volume (LVESV) from baseline to follow-up after cardiac resynchronization therapy (CRT). A reduction of >15% in LVESV is considered a marker of positive response to CRT and is associated with improved clinical outcomes

Interactive worksheet

LV Lead Position Index (LVLPI) Calculator

LV Lead Position Index (LVLPI): Explanation and Clinical Context The LV Lead Position Index (LVLPI) is a quantitative measure used to assess the position of the left ventricular (LV) lead relative to the apical and basal segments of the LV in patients undergoing cardiac resynchronization therapy (CRT). It is calculated by dividing the distance from the LV lead to the apex of the left ventricle by the distance to the

Interactive worksheet

LVEF-based ICD Classifier

: Explanation and Clinical Context This tool classifies patients for implantable cardioverter-defibrillator (ICD) therapy based on Left Ventricular Ejection Fraction (LVEF), using widely recognized thresholds. A reduced LVEF < 35% is associated with a significantly higher risk of sudden cardiac death (SCD), making these patients candidates for ICD implantation for primary prevention. Patients with LVEF between 36-40%